U.S. regulators forcing PatientsLikeMe’s Chinese majority owner to sell its stake
Cambridge, Massachusetts-based PatientsLikeMe is being forced to find a new buyer for the company because of the iCarbonX divesture mandated by U.S. regulators.
China’s Qiming Venture Partners closing $650M fund, reaches $600M in healthcare investments
The Chinese venture firm has a heavy focus on technology, and has made many investments in the healthcare space. This is its fifth fund on the U.S.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
WuXi Healthcare Ventures closes a $290M fund to invest in U.S. and China life sciences startups
The cross-border investment firm now has $350 million under management. It's invested in some high profile biopharma companies - including Juno Therapeutics, Foundation Medicine and Novira Therapeutics.